Skip to main content
. 2020 Oct 7;21(19):7403. doi: 10.3390/ijms21197403

Figure 2.

Figure 2

BP inhibits migration and arrests the PDGF-induced A7r5 in the G0/G1 phase in a dose-dependent manner. (A) A wound-healing assay (upper panel, scale bar = 500 μm) and Oris system migrating assay (lower panel, scale bar = 500 μm) were performed since A7r5 was treated with PDGF (10 ng/mL) and BP (0, 25, 50, 75 and 100 µg/mL) for 24 h; (B) Cell cycle analysis through PI staining and following flow cytometry for the A7r5 after 24 h of PDGF (10 ng/mL) and BP treatment (0, 25 and 75 ug/mL); (C,D) Quantification of the Oris system migrating assay and cell cycle analysis. Data are expressed as the mean ± SEM. * p < 0.05, *** p < 0.001.